Objective: Airway complications (AC) remain a significant contributing factor of morbidity after lung transplantation (LT). The aim of this study was to identify risk factors for AC, and to review the outcomes after endoscopic and surgical treatment. Methods: From 1993 to 2006, 255 patients underwent LT. Seven retransplants and 34 patients not surviving beyond 7 days were excluded. The remaining patients were: 124 double LT (DLT), 85 single LT (SLT), 3 lobar LT and 2 liver-DLT, comprising 343 bronchial anastomoses at risk. Donor lungs were flushed with either modified Eurocollins W or Perfadex W . Bronchial anastomoses were telescoped when needed. Donor and recipient variables were recorded and analyzed by univariate and multivariate tests to identify risk factors for AC, and to assess differences between both complicated and non-complicated groups. Results: Among 343 bronchial anastomoses, 31 presented AC (9%) in 27 patients (12.6%): 22 stenoses, 5 dehiscences, and 4 malacias, at 2.6 AE 1.7 months post-transplant. Indications were 7 emphysema, 3 Alpha-1-antitrypsin deficiency, 12 cystic fibrosis ( p = 0.007), 4 pulmonary fibrosis, and 1 bronchiectasis. AC were observed in 4 SLT and 23 DLT ( p = 0.005). Incidence of AC did not differ between telescoped and non-telescoped anastomoses. By univariate analysis, AC were more frequent in grafts preserved with modified Eurocollins W ( p = 0.033), CMV infection/disease ( p = 0.027) and airway colonizations post-transplant ( p = 0.021). Other donor and recipient variables did not differ between groups. By multivariate analysis, intubation longer than 72 h, DLT, and airway colonizations post-transplant remained independently associated with AC. Survival did not differ between groups. Most patients were successfully treated with endoscopic procedures; three required reoperation (lobectomy, pneumonectomy, retransplantation). AC related mortality was 1%. Conclusions: The incidence of AC after LT is 12.6% with a related mortality of 1%, irrespective of the technique of bronchial anastomosis performed. DLT, airway colonizations, and prolonged intubation posttransplant are associated with AC. Either endoscopic procedures or surgical therapy resolve these complications in most cases. #
Introduction
Despite the improvements in surgical technique and organ preservation, airway complications (AC) remain a potential source of early morbidity and mortality after orthotopic lung transplantation (LT) [1] . In the early years, bronchial complications such as necrosis and dehiscence were the most frequent causes of morbidity and mortality after LT [2] . In the last decades, the incidence of AC has decreased dramatically, as a result of better surgical techniques, organ preservation and postoperative care, with a reported incidence of 10-15% per anastomosis and a related mortality rate of 2-3% [3] .
The lung is the only solid organ transplant in which the systemic arterial blood supply is not routinely anastomosed at the time of transplantation, and bronchial complications have been attributed to ischemia of the donor bronchus [3, 4] . Other potential factors such as rejection [5] , immunosuppression [6] , infections [7] or inadequate organ preservation [3] may compromise airway healing as well.
In 2001, we reported our initial experience in the management of AC after LT in a series of 151 telescoped bronchial anastomoses. The bronchial complication rate was 5.3%, and complicated patients required longer periods of postoperative mechanical ventilation [8] . Since then, the evolving technique of bronchial anastomosis and the introduction of new preservation solutions and immunosuppressive agents has led us to reassess the issue.
The purpose of this study was to review the incidence of AC in a large series of LT patients, to identify risk factors for AC, and to review the clinical outcomes after endoscopic and/or surgical treatment.
Patients and methods

Study population
From October 1993 to December 2006, 255 patients underwent LT at the Reina Sofía Hospital. Seven retransplant recipients and 34 patients not surviving beyond the first 7 days post-transplant were excluded from the analysis. The causes of death in the excluded recipients were unrelated to their bronchial anastomoses. The records of the remaining 214 patients (study group) were retrospectively reviewed. They were 49 right single LT (SLT), 36 left SLT, 124 double LT (DLT), 3 cadaveric lobar LT, and 2 combined liver-DLT, comprising 343 bronchial anastomoses at risk.
Donor lung assessment and procurement
Donors were assessed by a retrieving lung transplant staff from our program. All donors met the standard criteria for donor lung acceptability [9] : age less than 55 years, PaO 2 / FiO 2 ratio above 300 mmHg, clear chest radiographs, tobacco history less than 20 pack-years, absence of purulent secretions or aspiration on bronchoscopy, and absence of macroscopic lung abnormalities at the time of retrieval.
The donor lung procurement was performed following the standard technique of combined cardiopulmonary extraction [10] . At the time of median sternotomy, the donor was given 10 mg/kg methylprednisolone (Solu-moderin. Pharmacia & Upjohn, Barcelona, Spain). After the heart and lungs were dissected free, the donor was systemically anticoagulated with 300 U/kg heparin. The aorta and pulmonary artery (PA) were each cannulated in turn, and 1 mg of prostaglandin E1 was administered directly into the donor main PA before cross-clamping the aorta. The lungs were flushed antegradely via the main PA, venting the perfusate through the left atrial appendage. Throughout the period of perfusion and removal, the lungs were ventilated at tidal volume (FiO 2 < 1) and topically cooled. On completion of the perfusate, the heart was removed first, the trachea was double-stapled and transected, and the lungs were removed at end-tidal inflation. Immediately after lung harvesting, an additional retrograde second flushing of the preservation solution was given to optimize lung preservation by perfusing the bronchial circulation [11] . The lungs were stored in 4 8C of the preservation solution for transportation. At bench dissection, the donor bronchus was shortened to two rings proximal to the upper lobe takeoff and care was taken to preserve peribronchial tissue.
The preservation solution used was modified Eurocollins W (60 ml/kg; 4 8C, 30 cm H 2 O) until year 2001, from which Perfadex W solution (Vitrolife, Gothenburg, Sweden) was introduced routinely.
Operative technique
From 1993 to 2000, bronchial anastomoses were performed using a telescoping technique [12] with continuous absorbable 4-0 monofilament running suture to the membranous portion and interrupted mattress or figure of eight sutures to the cartilaginous portion with polydioxanone (PDS) (Ethicon, Sommerville, NJ). Thereafter, bronchial anastomoses were either telescoped or not depending on the preferences of the attending surgeon, bronchial size, and discrepancy between both donor and recipient bronchi.
Bronchial anastomoses were covered with peribronchial tissue. Direct bronchial artery revascularization was not used. In cadaveric lobar LT, both lower lobes were implanted with a telescoping technique in all cases, as described previously [13] .
After the bronchial anastomosis was completed, the pulmonary artery and the left atrium were anastomosed in a standard fashion. Cardiopulmonary bypass was instituted in case of inability to maintain the recipient on one lung during pneumonectomy or implantation, or in case of graft dysfunction after the first lung was implanted. After completion of the transplant, a fiberoptic bronchoscopy was undertaken to assess the viability of the bronchial anastomoses and to aspirate secretions in the airways.
Postoperative management
Patients were ventilated until they were able to maintain adequate gas exchange and tidal volumes. The objective was to achieve the weaning from mechanical ventilation within 48-72 h postoperatively.
Immunosuppression was based on a triple therapy: cyclosporine or tacrolimus, azathioprine or mycophenolate mofetil, and steroids. Methylprednisolone administration was begun intravenously in the operating room (10 mg/kg before reperfusion). Immediately after completion of the lung transplantation, cyclosporine (Sandimmun W ; Novartis, Basle, Switzerland) was started at doses enough to achieve blood levels of 350-400 ng/ml, and methylprednisolone was maintained at diminishing doses until the fourth postoperative day, to be switched to deflazacort (Dezacor W ; Hoechst Marion Roussel, Barcelona, Spain) (1.5 mg/kg/day). Azathioprine (Imurel W ; Medeva Pharma, Madrid, Spain) (2 mg/kg/day) was started 48-72 h postoperatively after obtention of donor and recipient cultures. However, mycophenolate mofetil (Cellcept W ; Roche Lab. Inc., Nutley, NJ) (2-3 g/day) instead of azathioprine was given in some patients. Patients with recurrent acute rejection episodes, cyclosporine-related toxicity or development of bronchiolitis obliterans syndrome (BOS), were switched from cyclosporine to tacrolimus (Prograf W ; Fujisawa Killorglin Co., Kerry, Ireland) at doses enough to achieve blood levels of 10-20 ng/ml. No cytolytic therapy was systematically used.
BOS was diagnosed by transbronchial lung biopsy and/or when no other explanation for persistent declines in forced expiratory volume in 1 s (FEV 1 ) could be found. Episodes of acute rejection were diagnosed by clinical criteria and transbronchial lung biopsy in the absence of a positive bronchoalveolar lavage culture, and were treated with bolus doses of methylprednisolone (10 mg/kg/day) for three consecutive days.
Antimicrobial therapy was administered based on antibiotic sensitivities from preoperative sputum cultures of the recipient and from the donor bronchoaspirate. Viral and fungal prophylaxis was established following previous reports [14] . In patients with a documented airway fungal colonization, and those with AC treated with endoscopic procedures, systemic voriconazol for 2 weeks and aerosolized amphotericin B for 3 months were administered routinely. In addition, oral nystatin was administered to cystic fibrosis recipients.
Postoperative bronchoscopies were performed 24-48 h post-transplant, at the time of extubation and at discharge, and thereafter whenever a clinical suspicion of infection or rejection appeared. Late postoperative routine surveillance bronchoscopies were not performed.
Endoscopic management
The endoscopic treatment of patients with AC included at least one or a combination of the following: dilation with the use of rigid bronchoscopes of increasing diameter, balloon dilation under flexible bronchoscopy, placement of Dumon silicone stents (Bryan, Woburn, MA) or self expandable metal stents (Ultraflex W , Boston Scientific, Galway, Ireland), and Nd-YAG laser resection for debridement of granulation tissue.
Definitions
For the purpose of this study, an airway complication was defined as a finding of dehiscence, anastomotic or nonanastomotic stenosis, or malacia of the airway either requiring intervention (surgery, dilatation, debridement, laser therapy or stent placement) or only conservative measures. Bronchoscopy and CTscans were the most important diagnostic tools to define an airway complication.
Data collection and statistical analysis
All data were collected retrospectively. To identify predictors of AC, general demographic data, surgical and other postoperative variables were recorded. Factors evaluated were donor factors (age, gender, PaO 2 /FiO 2 , length of intubation, preservation solution used), preoperative recipient factors (age, gender, diagnosis, preoperative steroid therapy, need of preoperative mechanical ventilation), operative factors (type of LT, use of cardiopulmonary bypass, ischemic times, type of bronchial anastomosis, need of graft tailoring), and postoperative recipient factors (PaO 2 / FiO 2 , length of intubation, ICU and hospital stay, type of AC, infectious complications, incidence of BOS, survival). Pearson's chi-square test and Fisher's exact test were used to assess differences between categorical variables. MannWhitney test was used to compare means between two quantitative variables. Actuarial survival was calculated using Kaplan-Meier method and log-rank test.
A multiple stepwise logistic regression model was constructed to determine independent predictors of AC.
Variables entered in the model were those exhibiting p values less than 0.25 in the univariate analysis and other variables of clinical relevance: recipient length of intubation (>72 h), type of preservation solution (modified Eurocollins W vs Perfadex W ), recipient age (<20 years old), indication for LT (cystic fibrosis vs other), type of LT (SLT vs DLT), type of bronchial anastomosis (telescoped vs end-to-end), recipient airway colonizations from 30 to 90 days post-transplant (no/ yes), pneumonia episodes from 30 to 90 days post-transplant (no/yes). Variables remaining with p values less than 0.10 at the final step were considered independent predictors of AC.
Unless otherwise specified, data are presented as mean AE SEM for continuous data and as counts and proportions for categorical data. In the univariate analysis, differences were considered significant for p values less than 0.05. The statistical analysis was performed using SPSS (SPSS 11.0 for Windows: SPSS Inc., Chicago, Ill).
Results
Patient analysis
Three hundred and forty-three bronchial anastomoses were reviewed in 214 recipients. Thirty-one AC (9%) occurred in 27 patients (12.6%; CI: 8.5-16.6%). They were 16 men (59%) and 11 women (41%) with mean age of 36 AE 3 years (range 12-62 years). Table 1 Comparison of donor and recipient preoperative factors between both complicated and non-complicated patients (univariate analysis) Patients aged less than 20 years old presented higher incidence of AC than those older than 20 years (9/32 vs 18/ 155, respectively) ( p = 0.047), and 44% of AC developed in LT recipients with cystic fibrosis. However, when the subgroup of cystic fibrosis was compared to non-cystic fibrosis patients, these differences did not reach statistical significance (Table 1) . Also, recipient preoperative Gram negative airway colonizations were associated with a higher incidence of AC ( p = 0.032) ( Table 1) . Preoperative steroid therapy and need of mechanical ventilation at the time of transplantation were not found to be associated with AC.
In the univariate analysis, AC were more frequent in patients undergoing DLT. Twenty-three AC patients underwent bilateral anastomoses as opposed to only four patients with right bronchial anastomoses ( p = 0.005) ( Table 2 ). Also, patients receiving grafts preserved with modified Eurocollins W solution presented more AC than those preserved with Perfadex W (23/120 vs 4/67, respectively; p = 0.033). Ischemic times, and need of either cardiopulmonary bypass or graft tailoring on completion of the transplant, were factors not associated with the onset of AC (Table 2) .
Postoperatively (Table 3) , the length of mechanical ventilation did not differ between both complicated and non-complicated patients. Twenty-one patients with AC required intubation periods longer than 72 h, as opposed to only six complicated patients who were weaned within 72 h after transplantation (differences not significant).
However, patients with AC required longer ICU and hospital stays.
Infectious complications have been found to be closely associated to the onset of AC. Thus, the airway of complicated patients was more frequently colonized by Gram negative ( p = 0.008) and Gram positive bacteria ( p = 0.06), as well as by Aspergillus ( p = 0.037), between 30 and 90 days post-transplant. Also, in this period, episodes of bacterial pneumonia were more frequent in AC patients. Finally, CMV infection and/or disease was present more frequently in AC patients from 30 to 90 days posttransplant ( p = 0.07) and after 90 days post-transplant ( p = 0.027) than in those non-complicated patients (Table 3) .
Bronchial anastomoses analysis
Among 343 bronchial anastomoses at risk, 31 presented AC. Five partial dehiscences were diagnosed in four patients within the first month post-transplant. Twenty-two stenoses developed in 20 patients at 2.6 AE 1.7 months post-transplant. Bronchomalacia occurred in four airways of three patients at 4 AE 2 months post-transplant.
One patient with partial dehiscence progressed to stenosis after resolution of the dehiscence with a stent. Another patient with non-anastomotic stenosis progressed to bronchomalacia after retrieval of the stent previously implanted.
From 22 stenoses, 11 were at the site of anastomosis (50%), 7 were non-anastomotic (32%), and 4 stenoses developed both at the anastomotic site and distally (18%).
Bronchial anastomoses were telescoped in 245 cases (71%) and end-to-end in 98 (29%). AC developed in 10% of telescoped anastomoses (24/245) and in 7% of end-to-end anastomoses (7/98) ( p = 0.21). In 20 DLT with different bronchial anastomotic technique in either side, telescoped in one side and end-to-end in the other, there were no differences in the onset of AC between each side.
During the first 7 years of our transplant program (until year 2000), all grafts were preserved with modified Eurocollins W and their bronchial anastomoses were all telescoped. After year 2000, Perfadex W was introduced as the preservation solution of choice, and an end-toend bronchial anastomosis was performed in some patients. Therefore, we compared the incidence of AC before and after year 2000. In the early experience (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) , from 102 transplanted patients, 12 (11.7%) developed some AC. In the late experience (2001) (2002) (2003) (2004) (2005) (2006) , from 153 transplanted patients, 15 (9.8%) developed AC ( p = 0.91).
Multivariate analysis
Predictors from the univariate analysis with a p value less than 0.25 entered in the multivariate analysis. Also, other variables of clinical relevance were included: donor length of intubation, recipient age less than 20 years old, and type of bronchial anastomosis. Although cystic fibrosis patients and those grafts preserved with modified Eurocollins W were associated with the development of AC in the univariate analysis, these factors did not reach statistical significance in the multivariate analysis. On the contrary, recipient length of intubation longer than 72 h was found to be an independent predictor of AC in the multivariate analysis. The other variables remaining independent predictors of development of AC were DLT and airway colonizations between 30 and 90 days post-transplant (Table 4) .
Treatment and outcomes
Two patients died as a result of their AC (1%). Both patients developed a unilateral dehiscence after DLTand died on 30 and 47 days post-transplant due to sepsis and multiorganic failure. Since most AC appeared within the first 6 postoperative months, we excluded from the survival analysis those patients dying within 6 months post-transplant, to assess the real impact of AC on long-term survival. Actuarial survival did not differ between both complicated and non-complicated patients (Fig. 1) . The management of AC included a variety of procedures, from conservative measures to transplantectomy or retransplantation.
Three partial dehiscences in two patients were successfully treated with a covered Ultraflex W stent insertion, allowing complete healing of the anastomosis. One of these anastomoses developed granulation stenosis further, requiring laser debridement under rigid bronchoscopy and Dumon stent placement.
Among 22 bronchial stenoses, 5 were mild stenoses that did well with conservative measures. The remaining 17 bronchial stenoses underwent endoscopic treatment: balloon dilatation under flexible bronchoscopy, airway dilatation with rigid bronchoscopy, laser ablation and stent placement. Some patients required repeated stent placement due to migration, obstruction of upper lobe bronchi and/or development of exophytic granulation tissue. Granulation tissue was successfully managed by laser ablation in all cases. Three patients with stenoses required further surgical resection. One patient with a right non-anastomotic stenosis developed repeated episodes of middle and lower lobes pneumonia after several failed balloon dilation procedures, and underwent a lower and middle bilobectomy 4 months posttransplant. A subsequent bronchial stump fistula appeared so a completion pneumonectomy was performed 1 month later. Two patients with cystic fibrosis undergoing DLT and combined liver-DLT, respectively, developed right graft destruction after severe long stenoses not amenable at dilatation, and both a right retransplantation and a right pneumonectomy were performed, respectively. Four malacic airways developed in three pediatric patients undergoing DLT for cystic fibrosis. All cases were successfully treated by Ultraflex W stent placement.
Discussion
Airway complications continue to be an important source of morbidity after lung transplantation and, despite the improvements in organ preservation, patient selection, surgical technique, critical care, and immunosuppressive therapy, its prevalence has remained unchanged during the last 15 years [1, 3, 7, 8] . In our present experience, the rate of bronchial complications has raised up to 12.7% of patients (9% of bronchial anastomoses), as compared with our early experience (6.8% of patients) [8] . However, this incidence remains within the range of that reported in other large series [1, 4, 7, [15] [16] [17] with no differences on long-term survival (Fig. 1) . These findings might be explained by the larger number of patients analyzed, the liberalization of patient selection criteria, and the large proportion of cystic fibrosis and pediatric patients in our series. Thus, patients aged less than 20 years old presented higher incidence of AC than those older than 20 years, and 44% of recipients with AC were cystic fibrosis patients.
The bronchial anastomosis in lung transplantation is unique in that there is no direct blood supply to the bronchus to promote healing. Without reconnection of the bronchial arterial circulation, airway viability is exclusively dependent on the retrograde blood flow from pulmonary to bronchial circulation. Maintenance of blood flow through these capillaries is critical for the healing of the airway anastomosis until systemic neovascularization of the bronchial circulation through collaterals occurs, which may take up to 3 or 4 weeks. Thus, bronchial ischemia has been reported as the major factor in the pathogenesis of AC [3, 4] .
Several techniques have been developed to protect the bronchial anastomosis such as keeping the donor bronchus as short as possible and wrapping the anastomosis with vascularized pedicles [3] . Also, direct revascularization of the donor bronchial arteries has been attempted [18] , however, this technique faces the surgeon with an additional considerably demanding operative effort, and there is no evidence to support its use as superior to current airway anastomotic techniques without bronchial revascularization. Our standard technique includes keeping both recipient and donor bronchi short, and wrapping the anastomoses with peribronchial tissue. Also, as reported previously [11] , we routinely perform a double antegrade and retrograde flush perfusion of donor lungs to preserve the bronchial circulation.
The ideal technique of bronchial anastomosis has been a major concern in assessing AC after lung transplantation. In the early years, the telescoping technique proved to be useful in preventing bronchial anastomotic complications [3] . More recently, the end-to-end bronchial anastomosis has been reported to be associated to less incidence of AC [1, 17, 18] and has gained widespread use. Other authors have performed an end-to-end single running suture in lobar transplantation with excellent results [19] . For that reason, we introduced the end-to-end anastomosis from year 2000 in selected cases, such as some pediatric recipients and those with small size bronchi, in which a telescoped anastomosis could lead to significant stenosis. Nevertheless, in our experience, some degree of size discrepancy between donor and recipient bronchi was present in most cases, and no attempt at performing an end-to-end anastomosis was done when an evident size bronchial discrepancy was seen. We have not observed differences in the incidence of AC between telescoped and end-to-end anastomoses. Probably, other factors such as the careful surgical technique itself, the optimal organ preservation, and the early postoperative graft function leading to an early weaning from mechanical ventilation may play an important role in preventing AC. Furthermore, there were no differences in the onset of AC in those patients undergoing DLT with a different bronchial anastomotic technique at each side.
In our series, almost half of AC developed in cystic fibrosis patients. However, diagnosis of cystic fibrosis was not independently associated to the development of AC on multivariate analysis. The dominance of AC occurring in patients with cystic fibrosis has been previously reported. Ramirez et al. [20] noted that airway necrosis was seen in 12% and bronchial stenosis in 24% of their recipients with cystic fibrosis. Whether this is related to an increased propensity of this group of patients to experience infection and rejection remains unclear.
Double lung transplantation has been the dominant factor correlated with the development of AC both in univariate and multivariate analyses. From 27 patients with bronchial complications, 23 underwent DLT (Table 2) . Furthermore, the multivariate analysis demonstrated a 7.4-fold risk for AC in those patients receiving a DLT (Table 4 ). This finding was observed in our early experience [8] . As ischemic times and need of cardiopulmonary bypass did not differ between groups in DLT recipients, we hypothesize that the need of the retrograde collateral blood flow to be distributed into both grafts might make them more prone to develop AC.
The influence of mechanical ventilation in the onset of AC is controversial. Although some reports have described the beneficial effect of PEEP in favoring the retrograde collateral blood flow to reach the bronchial anastomosis [21] , the deleterious impact of a maintained positive ventilation pressure on the bronchial mucosa has been argued as well [1] . In our early experience, mechanical ventilation was associated with AC [8] . Our present study corroborates this finding, being the postoperative mechanical ventilation longer than 72 h an independent predictor of AC, with a 3.5-fold risk higher than those being weaned from mechanical ventilation within 72 h post-transplant (Table 4) .
Early graft dysfunction has been associated with AC by some investigators. Ruttmann et al. [16] demonstrated that severe reperfusion edema is the main predictor of later bronchial complications, and that edema formation is the only factor associated with prolonged postoperative ventilation. We did not assess the relationship between early graft dysfunction and the incidence of AC. Nevertheless, both complicated and non-complicated patients exhibited similar PaO 2 /FiO 2 ratios on completion of the lung transplant, and only the postoperative mechanical ventilation longer than 72 h (as one of the defining criteria for early graft dysfunction) was significantly different between both groups. It is unlikely that the mechanical ventilation itself is related with the development of AC. Probably, those factors leading to a need of prolonged intubation postoperatively, such as early graft dysfunction, infections or hemodynamic instability, might play a role in the pathogenesis of AC.
The relationship of AC with infections is well documented. Some investigators have reported a strong correlation between the presence of Apergillus, bronchial wall necrosis and occurrence of AC [22] . The role of postoperative fungal infection was also demonstrated in a recent report on AC after pediatric lung transplantation [15] . In our experience, those patients with AC presented more frequently with Gram negative colonizations (Pseudomonas cepacia), CMV infection and/or disease, and Aspergillus colonizations between 30 and 90 days postoperatively, when AC more often appeared. In the multivariate analysis, patients with airway colonizations were associated with a 3.2-fold increased risk of developing AC than those without airway colonizations (Table 4) . Also, patients with AC presented a higher incidence of pneumonia from 30 to 90 days post-transplant. Nevertheless, it is possible that postoperative pneumonia may have been the cause rather than the consequence of poor anastomotic healing.
In the univariate analysis, those grafts preserved with modified Eurocollins W solution were associated with AC as compared to those preserved with Perfadex W . However, these differences did not reach statistical significance in the multivariate analysis. Other confounding factors such as the different anastomotic technique used or the learning curve may have biased this observation. Therefore, from our results, we cannot state that the use of Perfadex W solution has a beneficial effect in preventing the onset of AC after transplantation. To assess whether the learning curve had an impact on AC development we analyzed the bronchial anastomoses between early (before year 2000) and late (after year 2000) lung transplants, and no differences were observed between both periods.
As reported previously, mild to moderate doses of steroids prior to lung transplant do not have deleterious effects on bronchial healing [23] . In our early experience [8] , and in the present series, low doses of preoperative prednisone were not related to the development of AC. Other variables such as donor factors have not been associated with the onset of AC. This might be due to the fact that all donors were optimal, with little variation in the acceptability criteria between both groups of recipients (Table 1) .
Several treatment modalities have been reported for the management of AC after lung transplantation. These include balloon dilation, silicone or expandable stents placement, laser therapy, and surgery. Anastomotic obstruction caused by exophytic granulation tissue can usually be managed by rigid bronchoscopy with or without laser debridement [7] . Also, silicone stent placement may be an option after laser debridement. Scar or ischemic stenoses at the anastomotic site or distal to the anastomosis have been treated successfully with repeated dilations under rigid bronchoscopy or balloon dilations under flexible bronchoscopy, with laser debridement and either silicone or expandable metal stents [24] . When the stenosis extends down into the upper and lower bronchi, lobectomy, pneumonectomy or retransplant may be the only solution [25] . In our experience, the possibility of a surgical resection for those patients with distal AC complicating the lung parenchyma is an option to be considered.
Bronchial dehiscence remains a disastrous complication after lung transplantation. Partial dehiscences can be treated expectantly, and usually heal satisfactorily when an adequate pleural drainage maintains the lung parenchyma expanded. Complete dehiscences are generally catastrophic and an attempt at repair is appropriate as an initial step, but it has a high failure rate and may result in transplant pneumonectomy.
Malacic airways are more frequently present in pediatric lung recipients and in those stenotic airways treated with stents. Usually, the insertion of a self expandable metal stent resolves the problem in most cases.
Several limitations must be considered in evaluating the results reported herein. First, the study was retrospective and patients were not randomly assigned to a specific surgical technique, therefore, only historical comparisons were possible. Second, the criteria for telescoping or not telescoping the bronchial anastomosis were based on the preferences of the attending surgeon; subtle differences among surgeons are undocumented and so could not be assessed. Third, methods of lung preservation, immunosuppression and postoperative management have evolved with time, and some other potential factors may have been missed in the analysis. Evaluating risk factors in the clinical setting is challenging and to demonstrate whether a single factor is a cause or a consequence of another is difficult. Finally, we have not graded AC following previous classification systems [3] but only on clinical judgment of the bronchoscopist, therefore, the severity of AC was based on the subjectivity of the observer.
In conclusion, the incidence of airway complications after lung transplantation is 12.6% (CI: 8.5-16.6%) with a related mortality of 1%. In our experience, the technique of bronchial anastomosis does not have an impact on the development of airway complications. On the contrary, those patients receiving double lung transplants, those with airway colonizations postoperatively, and those requiring mechanical ventilation for periods longer than 72 h post-transplant are at risk of developing airway complications. Either endoscopic procedures or surgical therapy resolve these complications in the majority of cases.
